FDA medical device approvals get external review

Sep 23, 2009 By MATTHEW PERRONE , AP Business Writer

(AP) -- The Food and Drug Administration is asking the government's top medical advisers to review its system for approving certain types of medical devices, which has been criticized by safety advocates and government watchdogs.

The nonprofit Institute of Medicine will conduct a two-year review of FDA's so-called 510k review procedure, which allows device companies to quickly launch products similar to those already on the market.

The announcement Wednesday garnered approval from lawmakers on Capitol Hill who have been skeptical of the FDA program.

"I have long been concerned that the 510k process permits too many devices on the market about whose safety and effectiveness even the FDA is uncertain," said Rep. Henry Waxman. "The result is hundreds of recalls of important devices for serious safety concerns."

The California Democrat chairs the House Energy and Commerce Committee, which oversees the FDA.

The procedure was originally intended to speed the approval of simple devices like bandages and wheelchairs, but in recent years it has been used to approve high-risk devices.

The Government Accountability Office, Congress' investigative arm, recently identified two-dozen device types that were approved without close scrutiny, including hip replacements and heart implants.

Normally, companies have to submit the results of large patient studies before launching such devices. But by arguing that their devices are similar to other FDA-approved products, companies can speed up the approval process. Under the 510k system, manufacturers simply have to give the FDA 90 days notice of their intent to launch their product.

The FDA said in a statement that medical technology has changed quickly in recent decades "making it an appropriate time ... to review the adequacy of the pre-market notification program."

The Institute of Medicine's review is expected to cost $1.3 million and its findings will be published in March 2011, according to the FDA.

The Advanced Medical Technology Association, which represents device makers like Medtronic Inc. and Boston Scientific Corp., called the 510k process a "well-defined, science-driven method." The trade group urged the institute to seek input from industry experts.

The institute, which advises the federal government on medical issues, is expected to hold two workshops in coming months to gather comments from industry, physicians and patients.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Mirabegron for overactive bladder: Added benefit not proven

add to favorites email to friend print save as pdf

Related Stories

FDA approves cervical disk device

Jul 17, 2007

The U.S. Food and Drug Administration Tuesday announced approval of the first device designed to treat cervical degenerative disc disease.

FDA requires faster food safety reporting

Sep 08, 2009

(AP) -- Food makers will be required to alert government officials of potentially contaminated products within 24 hours under a new rule designed to help federal regulators spot food safety issues sooner.

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

12 hours ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments : 0